Invenergy Wind

Shares of Gilead Sciences, Inc. (NASDAQ: GILD) were up 0.42 percent in after-hours Monday on relatively high volume, after gaining 0.54 percent over the trading session. The rise was driven by the approval of its hepatitis C virus (HCV) drug Harvoni in Japan. Among the biggest gainers after the...